I am often asked to evaluate patients with a disease of the cornea called ectasia. This is a group of conditions where the cornea becomes thin and unstable. The result is that the cornea takes on a conical shape compared to its normal spherical contour. The most common type of ectasia is keratoconus. This is a condition often diagnosed in adolescence when patients note a change in their glasses prescription with increasing astigmatism. An analysis of the corneal shape, called topography, reveals signs of thinning with associated changes in the corneal shape. Currently there is no cure for this disease. Therapies are used to improve vision and include contact lenses, intrastromal corneal inlays, and even corneal transplantation. We are fortunate because a treatment has become available for Keratoconus and other ectasias. This procedure is called corneal collagen crosslinking. Eyecare Medical Group was proud to be a part of the investigative trial for this technology. The treatment aims to strengthen the cornea and prevent progressive thinning and warpage of the cornea. Our results are very promising and many of our patients were able to benefit from this treatment as part of the investigative trial. This is a major milestone in the treatment of ectasias and EMG is excited to be able to offer this treatment to our patients.